[
    "{\"step_by_step_thinking\": \"Document 0 mentions that patients with Von Hippel-Lindau (VHL) disease were treated with pazopanib and showed partial response. Document 1 and 2 also provide evidence of the effectiveness of pazopanib in treating VHL disease. Therefore, it can be concluded that pazopanib can be used for the treatment of VHL disease.\", \"answer_choice\": \"A\"}"
]